Followers | 149 |
Posts | 17898 |
Boards Moderated | 0 |
Alias Born | 04/12/2012 |
Thursday, May 25, 2017 12:42:34 AM
Weekly Recap From the Expedition Lead Scientist
https://www.nasa.gov/mission_pages/station/research/news/wklysumm_week_of_15may17.html
Investigation studies effect of new drug on osteoporosis
When people and animals spend extended periods of time in space, they experience bone density loss, or osteoporosis. In-flight countermeasures, such as exercise, prevent it from getting worse, but there isn’t a therapy on Earth or in space that can restore bone that is already lost. The Systemic Therapy of NELL-1 for osteoporosis (Rodent Research-5) investigation tests a new drug that can both rebuild bone and block further bone loss, improving health for crew members.
Exposure to microgravity creates a rapid change in bone health, similar to what happens in certain bone-wasting diseases, during extended bed rest and during the normal aging process. The results from this ISS National Laboratory-sponsored investigation build on previous research also supported by the National Institutes for Health and could lead to new drugs for treating bone density loss in millions of people on Earth.
Research seeks to understand the heart of the matter
Exposure to reduced gravity environments can result in cardiovascular changes such as fluid shifts, changes in total blood volume, heartbeat and heart rhythm irregularities, and diminished aerobic capacity. The Fruit Fly Lab-02 study will use the fruit fly (Drosophila melanogaster) to better understand the underlying mechanisms responsible for the adverse effects of prolonged exposure to microgravity on the heart. Flies are smaller, with a well-known genetic make-up, and very rapid aging that make them good models for studying heart function. This experiment will help to develop a microgravity heart model in the fruit fly. Such a model could significantly advance the study of spaceflight effects on the cardiovascular system and facilitate the development of countermeasures to prevent the adverse effects of space travel on astronauts.
Recent ENDV News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM